Literature DB >> 14747596

A survey of hepatitis C prevalence amongst the homeless community of Oxford.

Luke C H Sherriff1, R T Mayon-White.   

Abstract

Hepatitis C (HCV) is an emerging health concern across the world, with 170 million people chronically infected and at risk of liver cancer, cirrhosis or liver failure. There is no vaccination and so it is important to learn as much as possible about how to prevent future infection. Modes of transmission include intravenous drug use (IDU), blood products, tattooing and, to a lesser extent, sexual intercourse. Homelessness is a risk factor of HCV because of the environments and behaviours associated with homeless communities such as poor hygiene, poor nutrition and high levels of IDU. The aim of this project was to determine the prevalence of HCV and its risk factors amongst the homeless community of Oxford, which is the second largest in the country. Ninety-eight individuals of the Oxford homeless community were interviewed and tested for HCV. The results gave an estimated HCV prevalence of 26.5 percent. The major risk factors in this population were IDU (past and present), age (over 20 years old) and sharing the paraphernalia used by i.v. drug users (e.g. spoons, foil and filters). With the exception of age, these risk factors could all be targeted in an attempt to reduce this prevalence and combat the major public health concern that HCV poses to the homeless community of Oxford.

Entities:  

Mesh:

Year:  2003        PMID: 14747596     DOI: 10.1093/pubmed/fdg088

Source DB:  PubMed          Journal:  J Public Health Med        ISSN: 0957-4832


  8 in total

1.  Hepatitis C among clients of health care for the homeless primary care clinics.

Authors:  Aaron J Strehlow; Marjorie J Robertson; Suzanne Zerger; Catherine Rongey; Lisa Arangua; Ed Farrell; Adele O'Sullivan; Lillian Gelberg
Journal:  J Health Care Poor Underserved       Date:  2012-05

Review 2.  Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.

Authors:  Rania A Tohme; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

3.  Giving away used injection equipment: missed prevention message?

Authors:  Carol Strike; Daniel Z Buchman; Russell C Callaghan; Cass Wender; Susan Anstice; Brian Lester; Nick Scrivo; Janine Luce; Margaret Millson
Journal:  Harm Reduct J       Date:  2010-02-09

4.  Exposure to hepatitis C virus in homeless men in Central Brazil: a cross-sectional study.

Authors:  Priscilla Martins Ferreira; Rafael Alves Guimarães; Christiane Moreira Souza; Lara Cristina da Cunha Guimarães; Cleiciane Vieira de Lima Barros; Karlla Antonieta Amorim Caetano; Giovanni Rezza; Lila Spadoni; Sandra Maria Brunini
Journal:  BMC Public Health       Date:  2017-01-18       Impact factor: 3.295

5.  Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.

Authors:  Liesl M Hagan; Ana Kasradze; Stephanie J Salyer; Amiran Gamkrelidze; Maia Alkhazashvili; Gvantsa Chanturia; Nazibrola Chitadze; Roena Sukhiashvili; Marina Shakhnazarova; Steven Russell; Curtis Blanton; Giorgi Kuchukhidze; Davit Baliashvili; Susan Hariri; Stephen Ko; Paata Imnadze; Jan Drobeniuc; Juliette Morgan; Francisco Averhoff
Journal:  BMC Public Health       Date:  2019-05-10       Impact factor: 3.295

6.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16

Review 7.  Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis.

Authors:  Ulla Beijer; Achim Wolf; Seena Fazel
Journal:  Lancet Infect Dis       Date:  2012-08-20       Impact factor: 25.071

8.  High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population.

Authors:  Robert W Aldridge; Andrew C Hayward; Sara Hemming; Susan K Yates; Gloria Ferenando; Lucia Possas; Elizabeth Garber; John M Watson; Anna Maria Geretti; Timothy Daniel McHugh; Marc Lipman; Alistair Story
Journal:  Thorax       Date:  2018-01-29       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.